Home
Clinical Resources Search
PQI: Social Determinants of Health in Cancer

Social Determinants of Health in Cancer

Download PQI pdf

Last Updated: December 19, 2023

By: Tahsin Iman, PharmD | Elizabeth Heard, PharmD

About this PQI

This PQI identifies social determinants of health (SDOH) as they relate to cancer patients and incorporates strategies to address patients’ social needs.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Social Determinants of Health in Cancer

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Tafasitamab-cxix (Monjuvi) for Relapsed/Refractory Follicular Lymphoma

PQI: Encorafenib (Braftovi) + Cetuximab (Erbitux) + FOLFIRI for BRAF V600E-Positive Metastatic Colorectal Cancer

PQI: Reflex Biomarker Testing in Metastatic Colorectal Cancer: Implementing BRAF and MSI Assessment

PQI: Amivantamab and Hyaluronidase plus Lazertinib Patient Management

PQI in Action: Inavolisib (Itovebi) Patient Management

PQI in Action: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI in Action: Capivasertib (Truqap) Patient Management

PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

S11 E4: From Data to Decisions: Decoding Prostate Cancer Updates

S11 E3: Beyond Borders: Bringing Cancer Treatment Within Reach

S11 E2: Navigating Life After Cancer

S11 E1: Fail First, Patients Last? Rethinking Step Therapy in Oncology

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bispecific (T-Cell Engager)

Treatment Support Kit: Avutometinib and Defactinib

Treatment Support Kit: Mirdametinib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Irinotecan

S8 Ep 10: Operationalizing Bispecifics in the Community Setting

The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings

The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program

Filgrastim

Pegfilgrastim

Pamidronate

How to Categorize Cancer Drug Therapy

PQI: Tafasitamab-cxix (Monjuvi) for Relapsed/Refractory Follicular Lymphoma

Emapalumab

Infliximab

Obinutuzumab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone